Your cart is currently empty.
- FSCDR’s Experience with Voxelotor (GBT440) Treatment in Patients with Severe Sickle Cell Disease December 14, 2017
- FSCDR Presents Positive Results from Case Study of Voxelotor (GBT440) in Sickle Cell Disease Patient October 31, 2017
- FDA approves new treatment for sickle cell disease: Endari July 14, 2017
- New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Crisis May 5, 2017
- Ribbon Cutting Press Release October 20, 2016